All In Biotech

Drug Trial Radar · NCT01114139

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia

Last checked: Nov 20, 2026Latest source record: Apr 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 812 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

812

Actual

Start

Jun 19, 2010

Primary completion

Feb 27, 2012

Study completion Oct 22, 2012

Sponsor

Lead sponsor
AMAG Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Apr 30, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).

Conditions

  • Iron Deficiency Anemia

Interventions

  • FerumoxytolDrug

    IV Ferumoxytol

  • PlaceboOther

    IV Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Participants Who Achieved A ≥2.0 g/dL Increase In Hemoglobin At Any Time From Baseline To Week 5Time frame: Baseline (Day 1) through Week 5

Locations

182 sites in 6 countries. Site status is shown where the registry gives one.

  • Clinical Trial Site

    Birmingham, Alabama

  • Clinical Trial Site

    Mobile, Alabama

  • Clinical Trial Site

    Montgomery, Alabama

  • Clinical Trial Site

    Montgomery, Alabama

  • Clinical Trial Site

    Green Valley, Arizona

  • Clinical Trial Site

    Phoenix, Arizona

  • Clinical Trial Site

    Phoenix, Arizona

  • Clinical Trial Site

    Tucson, Arizona

  • Clinical Trial Site

    Tucson, Arizona

  • Clinical Trial Site

    Alhambra, California

  • Clinical Trial Site

    Anaheim, California

  • Clinical Trial Site

    Bakersfield, California

  • Clinical Trial Site

    Buena Park, California

  • Clinical Trial Site

    Colton, California

  • Clinical Trial Site

    Fresno, California

  • Clinical Trial Site

    Glendale, California

  • Clinical Trial Site

    Laguna Hills, California

  • Clinical Trial Site

    Laguna Hills, California

  • Clinical Trial Site

    Lakewood, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Los Angeles, California

  • Clinical Trial Site

    Mission Hills, California

  • Clinical Trial Site

    Orange, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    San Diego, California

  • Clinical Trial Site

    Pueblo, Colorado

  • Clinical Trial Site

    Bristol, Connecticut

  • Clinical Trial Site

    Groton, Connecticut

  • Clinical Trial Site

    Newark, Delaware

  • Clinical Trial Site

    Boynton Beach, Florida

  • Clinical Trial Site

    Boynton Beach, Florida

  • Clinical Trial Site

    Clearwater, Florida

  • Clinical Trial Site

    Clearwater, Florida

  • Clinical Trial Site

    Hialeah, Florida

  • Clinical Trial Site

    Holiday, Florida

  • Clinical Trial Site

    Inverness, Florida

  • Clinical Trial Site

    Margate, Florida

  • Clinical Trial Site

    Miami, Florida

Showing 40 of 182 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.